跳至主要内容
临床试验/NCT05979246
NCT05979246尚未招募不适用

A Comparative Prospective Study to Evaluate the Effect of the Superhydrophilic Surface of Lance CLEAR Implants on the Marginal Bone Loss and Survival in Diabetic and Non Diabetic Patients

MIS Implant Technologies, Ltd0 个研究点目标入组 40 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
主要终点
marginal bone loss

研究概览

简要总结

The aim of this clinical, prospective study involving implants with a superhydrophilic surface is to compare the changes of the peri-implant tissues and the survival rate between diabetics and non-diabetics patients, after 12 months of loading.

hypothesis: It is not expected to find any short-term differences in failures and marginal bone loss between the diabetic and non-diabetic patients. On the longer term higher marginal bone loss may affect the diabetic group 40 patients who are planned to undergo implant installation will be enrolled in the study.

The patients will be divided into 2 groups:

  • Test group - 20 patients diagnosed with type 2 diabetes with 10>HbA1C>7.5% values
  • Control group - 20 non-diabetic patients.

详细描述

In recent years, our understanding of the primary processes that affect bone growth around implants has progressed. It was found that the standard surface of most implants is not hydrophilic enough; therefore, it is necessary to increase the healing time to allow sufficient bony apposition at the implant interface, until reaching a satisfactory load-bearing capacity. Studies have demonstrated that surface superhydrophilicity can be gained following storage in an isotonic solution (NaCl); this feature leads to an earlier bone apposition and higher anchorage, already after the very first weeks of implantation.

Hypothesis: It is not expected to find any short-term differences in failures and marginal bone loss between the diabetic and non-diabetic patients. On the longer term higher marginal bone loss may affect the diabetic group.

Aim:to compare the changes of the peri-implant tissues and the survival rate between diabetics and non-diabetics patients, after 12 months of loading.

Methods and Materials: 40 patients who are planned to undergo implant installation will be enrolled in the study, at the department of Periodontology at the School of postgraduate dentistry in the Rambam Health Care Center. .

The patients will be divided into 2 groups:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A properly signed and dated consent form.
  • The need to perform a dental implant (up to two dental implants will be selected for the patient).
  • The existence of sufficient alveolar bone that allows the installation of implants of standard size (diameter 3.75 or above and height of at least 8 mm).
  • Patients who will receive a fixed restoration (a crown or three units bridge)
  • A type 2 diabetes with 10 > A1C>7.5 % values but not above 10, or non-diabetic patient (control).
  • Meeting the study schedules and attending the study visits.

排除标准

  • The presence of an active periodontal disease (PD≥6 mm with bleeding on probing).
  • Smoking more than 10 cigarettes a day.
  • Pharmacological condition which can affect the healing of soft or hard tissue.
  • Past radiation therapy to the head and neck.
  • Patients under medications with known effects on bone metabolism (e.g. steroids, anti-TNF-α), antibiotics therapy in the previous months.
  • Impaired occlusion that can lead to pathologies.
  • Pregnancy and lactating.
  • A patient who needs local bone augmentation.
  • Using removable prosthesis in the implantation area.
  • Subjects who are currently enrolled, recently participated (within 30 days prior to screening), or planning to enroll in another study that may conflict with protocol requirements or may confound the subject results in this trial.

结局指标

主要结局

marginal bone loss

时间窗: one year after loading

radiographic bone resorption around the implant

次要结局

  • Survival rate(12 weeks after implantation)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验